Westside Investment Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-500
| Closed | -$7.48K | – | 857 |
|
|
2022
Q4 | $7.48K | Hold |
500
| – | – | 0.02% | 204 |
|
|
2022
Q3 | $4.12K | Hold |
500
| – | – | 0.01% | 225 |
|
|
2022
Q2 | $2.77K | Hold |
500
| – | – | 0.01% | 230 |
|
|
2022
Q1 | $2.77K | Hold |
500
| – | – | 0.01% | 232 |
|
|
2021
Q4 | $3.13K | Hold |
500
| – | – | 0.01% | 217 |
|
|
2021
Q3 | $3.13K | Hold |
500
| – | – | 0.01% | 216 |
|
|
2021
Q2 | $3.29K | Hold |
500
| – | – | 0.01% | 211 |
|
|
2021
Q1 | $3.66K | Hold |
500
| – | – | 0.01% | 200 |
|
|
2020
Q4 | $2.88K | Hold |
500
| – | – | 0.01% | 160 |
|
|
2020
Q3 | $2.97K | Hold |
500
| – | – | ﹤0.01% | 169 |
|
|
2020
Q2 | $2.58K | Sell |
500
-500
| -50% | -$3.16K | ﹤0.01% | 155 |
|
|
2020
Q1 | $54.1K | Buy |
+1,000
| New | +$4.96K | 0.04% | 78 |
|
|
2019
Q2 | $3K | Buy |
+300
| New | +$2.57K | 0.01% | 89 |
|
|
2018
Q4 | $5.97K | Hold |
300
| – | – | ﹤0.01% | 539 |
|
|
2018
Q3 | $6.81K | Buy |
300
+150
| +100% | +$3.85K | ﹤0.01% | 556 |
|
|
2018
Q2 | $4.28K | Buy |
+150
| New | +$3.56K | ﹤0.01% | 699 |
|
Westside Investment Management's AVEO Position: Q1 2023 in Review
Westside Investment Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 500 shares — an estimated $7.48K sold.
Westside Investment Management first reported a position in AVEO in Q2 2018 and held it in 16 quarters. The position peaked at $54.1K in Q1 2020. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Westside Investment Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Westside Investment Management sold 500 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $7.48K.
- Westside Investment Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2018 and held it in 16 quarters.
- Westside Investment Management's AVEO Pharmaceuticals, Inc. position peaked at $54.1K in Q1 2020.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Westside Investment Management's 13F filing for Q1 2023, filed 17 May 2023.